Parameters for individualizing systemic therapy in non-small cell lung cancer
about
The Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung Cancer.Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology.Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy.
P2860
Parameters for individualizing systemic therapy in non-small cell lung cancer
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Parameters for individualizing systemic therapy in non-small cell lung cancer
@en
Parameters for individualizing systemic therapy in non-small cell lung cancer.
@nl
type
label
Parameters for individualizing systemic therapy in non-small cell lung cancer
@en
Parameters for individualizing systemic therapy in non-small cell lung cancer.
@nl
prefLabel
Parameters for individualizing systemic therapy in non-small cell lung cancer
@en
Parameters for individualizing systemic therapy in non-small cell lung cancer.
@nl
P2093
P2860
P1476
Parameters for individualizing systemic therapy in non-small cell lung cancer
@en
P2093
Ann G Schwartz
Antoinette Wozniak
Gerold Bepler
Larry H Matherly
Michele L Cote
Shirish M Gadgeel
P2860
P304
P356
10.1016/J.DRUP.2010.10.001
P577
2010-11-03T00:00:00Z